Home/Filings/4/0000950170-25-043291
4//SEC Filing

Parikh Asit 4

Accession 0000950170-25-043291

CIK 0001783183other

Filed

Mar 20, 8:00 PM ET

Accepted

Mar 21, 4:46 PM ET

Size

6.7 KB

Accession

0000950170-25-043291

Insider Transaction Report

Form 4
Period: 2024-09-10
Parikh Asit
Director
Transactions
  • Exercise/Conversion

    Common Stock

    2024-09-10$11.72/sh+7,500$87,90093,000 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-09-107,5007,500 total
    Exercise: $11.72From: 2024-05-25Exp: 2033-05-24Common Stock (7,500 underlying)
Footnotes (1)
  • [F1]The amount in column 5 shows the amount beneficially owned as of the filing date of this report.

Documents

1 file

Issuer

Phathom Pharmaceuticals, Inc.

CIK 0001783183

Entity typeother

Related Parties

1
  • filerCIK 0001796787

Filing Metadata

Form type
4
Filed
Mar 20, 8:00 PM ET
Accepted
Mar 21, 4:46 PM ET
Size
6.7 KB